Bank of Montreal’s Oramed Pharmaceuticals ORMP Stock Holding History

Bank of Montreal’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-249,200	Closed	-$1.35M	–	4338
2022 Q2	$1.35M	Buy	+249,200	New	+$1.33M	﹤0.01%	2124
2021 Q2	–	Sell	-1,600	Closed	-$16K	–	4573
2021 Q1	$16K	Hold	1,600	–	–	﹤0.01%	4153
2020 Q4	$7K	Hold	1,600	–	–	﹤0.01%	4723
2020 Q3	$4K	Hold	1,600	–	–	﹤0.01%	4519
2020 Q2	$5K	Hold	1,600	–	–	﹤0.01%	4415
2020 Q1	$5K	Sell	1,600 -2,400	-60%	-$10.5K	﹤0.01%	3686
2019 Q4	$20K	Buy	4,000 +2,400	+150%	+$8.99K	﹤0.01%	4320
2019 Q3	$5K	Hold	1,600	–	–	﹤0.01%	4556
2019 Q2	$6K	Hold	1,600	–	–	﹤0.01%	4650
2019 Q1	$6K	Hold	1,600	–	–	﹤0.01%	3999
2018 Q4	$5K	Hold	1,600	–	–	﹤0.01%	4093
2018 Q3	$8K	Sell	1,600 -1,000	-38%	-$5.19K	﹤0.01%	3995
2018 Q2	$19K	Hold	2,600	–	–	﹤0.01%	3759
2018 Q1	$17K	Hold	2,600	–	–	﹤0.01%	3604
2017 Q4	$23K	Buy	2,600 +1,000	+63%	+$9.56K	﹤0.01%	3546
2017 Q3	$16K	Hold	1,600	–	–	﹤0.01%	3585
2017 Q2	$12K	Hold	1,600	–	–	﹤0.01%	3678
2017 Q1	$10K	Hold	1,600	–	–	﹤0.01%	3553
2016 Q4	$10K	Buy	+1,600	New	+$10.4K	﹤0.01%	3605
2016 Q3	–	Sell	-1,580	Closed	-$13K	–	4150
2016 Q2	$13K	Hold	1,580	–	–	﹤0.01%	3520
2016 Q1	$11K	Hold	1,580	–	–	﹤0.01%	3592
2015 Q4	$14K	Buy	+1,580	New	+$12K	﹤0.01%	3522

Other funds holding ORMP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's ORMP Position: Q3 2022 in Review

Bank of Montreal sold out of Oramed Pharmaceuticals (ORMP) in Q3 2022, closing a stake of 249,200 shares — an estimated $1.35M sold.

Bank of Montreal first reported a position in ORMP in Q4 2015 and held it in 22 quarters. The position peaked at $1.35M in Q2 2022. 71 funds tracked by Wall St. Rank hold ORMP as of Q3 2022.

Bank of Montreal reported no remaining Oramed Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 249,200 Oramed Pharmaceuticals shares in Q3 2022, an estimated $1.35M.
Bank of Montreal first reported a position in Oramed Pharmaceuticals in Q4 2015 and held it in 22 quarters.
Bank of Montreal's Oramed Pharmaceuticals position peaked at $1.35M in Q2 2022.
71 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.